1. Home
  2. LIMNW vs SATS Comparison

LIMNW vs SATS Comparison

Compare LIMNW & SATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIMNW
  • SATS
  • Stock Information
  • Founded
  • LIMNW N/A
  • SATS 2007
  • Country
  • LIMNW United States
  • SATS United States
  • Employees
  • LIMNW N/A
  • SATS N/A
  • Industry
  • LIMNW
  • SATS Telecommunications Equipment
  • Sector
  • LIMNW
  • SATS Consumer Discretionary
  • Exchange
  • LIMNW Nasdaq
  • SATS Nasdaq
  • Market Cap
  • LIMNW N/A
  • SATS N/A
  • IPO Year
  • LIMNW N/A
  • SATS 2007
  • Fundamental
  • Price
  • LIMNW $0.09
  • SATS $17.73
  • Analyst Decision
  • LIMNW
  • SATS Hold
  • Analyst Count
  • LIMNW 0
  • SATS 5
  • Target Price
  • LIMNW N/A
  • SATS $22.50
  • AVG Volume (30 Days)
  • LIMNW N/A
  • SATS 3.6M
  • Earning Date
  • LIMNW N/A
  • SATS 05-09-2025
  • Dividend Yield
  • LIMNW N/A
  • SATS N/A
  • EPS Growth
  • LIMNW N/A
  • SATS N/A
  • EPS
  • LIMNW N/A
  • SATS N/A
  • Revenue
  • LIMNW N/A
  • SATS $15,680,431,000.00
  • Revenue This Year
  • LIMNW N/A
  • SATS N/A
  • Revenue Next Year
  • LIMNW N/A
  • SATS N/A
  • P/E Ratio
  • LIMNW N/A
  • SATS N/A
  • Revenue Growth
  • LIMNW N/A
  • SATS N/A
  • 52 Week Low
  • LIMNW N/A
  • SATS $14.79
  • 52 Week High
  • LIMNW N/A
  • SATS $32.48
  • Technical
  • Relative Strength Index (RSI)
  • LIMNW N/A
  • SATS 31.50
  • Support Level
  • LIMNW N/A
  • SATS $19.56
  • Resistance Level
  • LIMNW N/A
  • SATS $23.73
  • Average True Range (ATR)
  • LIMNW 0.00
  • SATS 1.62
  • MACD
  • LIMNW 0.00
  • SATS -0.33
  • Stochastic Oscillator
  • LIMNW 0.00
  • SATS 2.73

About LIMNW Liminatus Pharma Inc. Warrants

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

Share on Social Networks: